Reagent B is a chemical solution used in various laboratory applications. It serves as a key component in analytical procedures, enabling the measurement and evaluation of specific analytes or samples. The precise function and intended use of Reagent B may vary depending on the specific application and laboratory protocol.
Daily imaging was done by phase contrast microscopy. Cell counts and viability were performed using the Nucleocounter NC3000 (Chemometec) as per manufacturer's instructions for two separate samples. Counts were performed directly on the microcarriers using the reagent A100 and reagent B protocol. Briefly, the cell‐microcarrier suspension was diluted to a 1:1:1 ratio with reagent A100 and reagent B (Chemometec); reagent A100 lyses the cells from the microcarriers releasing the nuclei, while reagent B stabilizes the suspension. The resulting suspension was loaded onto a Nucleocassette Via‐1, preloaded with acridine orange and DAPI and the cassette then transferred Nucleocounter NC3000 machine for processing. Spent medium samples were collected before and after medium exchanges in the bioreactor and were analyzed for glucose and lactate concentrations on an AccuTrend Plus meter (Roche). Fresh growth medium was used as baseline control. Based on cell counts, the following parameters were calculated:
Specific growth rate μ=lnCxtCx0∆t,where μ is the specific growth rate (h−1), Cx(t) and Cx(0) represent cell numbers at the end and start of the culture, t represents time in culture (h).
Doubling time td=ln2μ,where td is doubling time (h) and μ is the specific growth rate (h−1).
Fold increase FI=CxtCx0,where Cx(t) represents the maximum cell number and Cx(0) is the initial cell number.
Ochs J., Hanga M.P., Shaw G., Duffy N., Kulik M., Tissin N., Reibert D., Biermann F., Moutsatsou P., Ratnayake S., Nienow A., Koenig N., Schmitt R., Rafiq Q., Hewitt C.J., Barry F, & Murphy J.M. (2022). Needle to needle robot‐assisted manufacture of cell therapy products. Bioengineering & Translational Medicine, 7(3), e10387.
The number of cells adherent to the implant (n = 6–7/group/time point) or in the exudate (n = 8–9/group/time point), that were retrieved from animals, was measured using the NucleoCounter® system (ChemoMetec). To count cells adherent to the implants, retrieved implants were immediately immersed in lysis buffer (100 μL, Reagent A100, ChemoMetec) in a 96-well plate and shaken for 2 min at 500 RPM to detach the cells from the implant surface. Implants were then removed from the lysate before adding the stabilization buffer (100 μL, Reagent B, ChemoMetec). The cell sample was then loaded in a NucleoCassette™ containing propidium iodide that stains nuclei for automatic counting of total cells. To count cells in exudate, an exudate fraction was directly loaded in NucleoCassette™ for dead cell quantification. An additional exudate fraction was diluted 1:1:1 with lysis buffer and stabilization buffer and drawn into NucleoCassette™, as described above, to count total cells.
Ben Amara H., Martinez D.C., Shah F.A., Loo A.J., Emanuelsson L., Norlindh B., Willumeit-Römer R., Plocinski T., Swieszkowski W., Palmquist A., Omar O, & Thomsen P. (2023). Magnesium implant degradation provides immunomodulatory and proangiogenic effects and attenuates peri-implant fibrosis in soft tissues. Bioactive Materials, 26, 353-369.
The effect that the compounds 1a–6a exert on the melanoma cell number (in cell culture) was tested on a MEW155 human melanoma tumor cell line obtained from the Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology in Warsaw. The cells were plated in 24-well plates (5000 cells per well) and incubated for 24 h in Eagle’s medium containing 10% fetal bovine serum and 1% solution of penicillin and streptomycin. After the cells had reached 80% confluence, the tested compounds (dissolved in 1% DMSO) were added at a concentration of 50 μM. Control cells were treated with 1% DMSO only. After 96 h of incubation, the cell suspension was first lysed in lysis buffer (ReagentA, ChemoMetec A/S) and then stabilized in stabilization buffer (ReagentB, ChemoMetec A/S). The number of dead cells was quantified in a propidium iodide cassette with the use of a NucleoCounter® NC-100™ (ChemoMetec A/S) cell counter. The tests were performed in triplicate. The results were normalized so that the values obtained for the control were 100%.
Dyniewicz J., Lipiński P.F., Kosson P., Bochyńska-Czyż M., Matalińska J, & Misicka A. (2020). Antinociceptive and Cytotoxic Activity of Opioid Peptides with Hydrazone and Hydrazide Moieties at the C-Terminus. Molecules, 25(15), 3429.
PBMCs were quantified with an automated device based on propidium iodide (PI) staining and exclusion, the NucleoCounter NC-100 (ChemoMetec, Denmark). For total cell count, PBMCs were lysed and stabilized with reagent A and reagent B (ChemoMetec, Denmark), respectively, to expose all nuclei to PI staining. Counting of dead cells was performed without lysis treatment, and viability was calculated as the proportion between living cells and the total cell count and was expressed as a percentage.
Rusconi G., Cusumano G., Mariotta L., Canevascini R., Gola M., Gornati R, & Soldati G. (2022). Upgrading Monocytes Therapy for Critical Limb Ischemia Patient Treatment: Pre-Clinical and GMP-Validation Aspects. International Journal of Molecular Sciences, 23(20), 12669.
Cell pellets were resuspended by repeated pipetting in 400 μL Lysis Buffer (Reagent A100, Chemometec, Villeneuve-Loubet, France) before the addition of 400 μL Stabilizing Buffer (Reagent B, Chemometec). After centrifugation at 200 × g for 5 min, 700 μL supernatant was collected as the cytoplasmic fractions and the remaining 100 μL was kept as the nuclear fractions.
François A., Bouzelha M., Lecomte E., Broucque F., Penaud-Budloo M., Adjali O., Moullier P., Blouin V, & Ayuso E. (2018). Accurate Titration of Infectious AAV Particles Requires Measurement of Biologically Active Vector Genomes and Suitable Controls. Molecular Therapy. Methods & Clinical Development, 10, 223-236.
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to
get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required